Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Controlled Phase II Clinical Study

Phase 2 Not yet recruiting 76 enrolled Shanghai Zhongshan Hospital

RandomizedParallel-groupSingle-blindTreatment

Summary

Second-line regimen with or without consolidative radiotherapy in patients with oligometastatic/locally advanced unresectable intrahepatic cholangiocarcinoma: an open-label, randomised, controlled study.

Timeline

Start: 2025-06-01
Primary completion: 2027-05-31
Completion: 2027-05-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	Regorafenib	Small molecule	—	—

Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Controlled Phase II Clinical Study

Summary

Timeline

Drugs

Indications